WuXi stock plummets, wiping nearly $10B off market value as US adds it to ‘unverified’ list

As Covid-19 has made it more difficult for US regulators to carry out routine inspections, WuXi Biologics has been hit with unverified status, causing its stock to plummet, and wipe $9.9 billion off of its market value before trading of its shares was halted.